Brett Fleshman
Keine laufenden Positionen mehr
Profil
Brett Fleshman worked as a Senior Director of Strategy & Business Development at Cornerstone Therapeutics, Inc. and as a VP of Strategy & Corporate Development at Veloxis Pharmaceuticals A.
He received an undergraduate degree from Olin Business School.
Ehemalige bekannte Positionen von Brett Fleshman
| Unternehmen | Position | Ende |
|---|---|---|
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| VELOXIS PHARMACEUTICALS A/S | Public Communications Contact | - |
Ausbildung von Brett Fleshman
| Olin Business School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
